In 2073, scientists at the International Genomic Institute, led by Dr. Maya Liwanag, successfully eliminated Type 1 diabetes using 'GenEx,' a novel gene-editing technology. This breakthrough reprogrammed the autoimmune system to allow natural regeneration of insulin-producing cells in the pancreas. The advancement promises to revolutionize healthcare for millions affected by insulin dependence. Global efforts are underway to ensure equitable access to this groundbreaking treatment, heralding a new era in personalized medicine.